Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma

Journal of Clinical Pathology

Volumn 50, Issue 6, 1997, Pages 509-512

  González, M Victoria ^a   Pello, Marta F ^b   López Larrea, Carlos ^a   Suárez, Carlos ^b   Menéndez, María J ^a   Coto, Eliecer ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Serv de Otorrinolaringología

Author keywords

CpG island; Head and neck squamous cell carcinoma; Homozygous deletion; Methylation; Polymorphism (p16 p15); Single strand conformation; Turnout suppressor genes

Indexed keywords

DNA;

ARTICLE; CLINICAL ARTICLE; DNA METHYLATION; GENE DELETION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0030837110     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.6.509     Document Type: Article

References (33)

1. Decker J, Goldstein JC. Risk factors in head and neck cancer. N Engl J Med 1982;306:1151-5.
2. Nuǹez F, Dominguez O, Coto E, Suarez-Nieto C, Pėrez P, López- Larrea C. Analysis of ras oncogene mutations in human squamous cell carcinomas of the head and neck. Surg Oncol 1992;1:405-11.
3. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi V, Sumegi J. Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res 1989;80:430-7.
4. Wang X, Pavelic ZP, Li Y-Q, Wang L, Gleich L, Radack K, et al. Gene amplification and overexpression of the cyclin G1 gene in head and neck squamous cell carcinoma. J Clin Pathol: Mol Pathol 1995;48:M256-9.
5. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994;54:1152-5.
6. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1994;53:4477-80.
7. Van der Riet P, Nawroz H, Hruhan RH, Curio R, Tokino K, Koch W, et al. Frequent loss of chromosome 9p21 22 early in head and neck cancer progression. Cancer Res 1994;54: 1156-8.
8. González MV, Pello MF, López-Larrea C, Suárez C, Menėndez MJ, Coto E. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck. Clin Cancer Res 1994;1:1043-9.
9. Zhang S-Y, Klein-Szanto AJP, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumours of the head and neck. Cancer Res 1994;54:5050-3.
10. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4. Nature 1993;366:704-7.
11. INKI. Science 1995;267:249-52.
12. Liggett WH, Sewell DA, Rocco J, Ahrendt SA, Koch W, Sidransky D. p 15 and p16 are potent growth suppressors of head and neck squamous carcinoma cell in vitro. Cancer Res 1996;56:4119-23.
13. Caldas C, Hahn SA, Da Costa LT, Redstone MS, Schutte M, Seymour AB, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
14. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y. Frequent somatic mutations of the MTS1/CDK4 (multiple tumour suppressor/cyclin dependent kinase 4 inhibitor) gene in esophageal cell carcinoma. Cancer Res 1994;54: 3396-97.
15. INKI in human cancer. Proc Natl Acad Sci USA 1994;91:11045-9.
16. Spruck C, Gonzalez-Zulueta M, Shibata A, Simoneau A, Lin M, Gonzales F, et al. p16 gene in uncultured tumours. Nature 1994;370:183-4.
17. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, et al. Rates of p16 (MTS1) mutations in primary tumours with 9p loss. Science 1994;265:415-7.
18. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, et al. Deletion of p16 and p15 genes in brain tumours. Cancer Res 1994;54:6353-8.
19. González MV, Artimez ML, Rodrigo L, López-Larrea C, Menéndez MJ, Alvarez V, et al. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol 1997;50:212-17.
20. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, et al. Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-30.
21. González-Zulueta M, Bender CM, Yang AS, Nguyen TD, Beart RW, van Torout JM, et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumour suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995;5:4531-5.
22. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 1995;11:210-2.
23. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-92.
24. INKIH is a potential effector of TGF induced cell cycle arrest. Nature 1994;371:257-61.
25. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
26. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in the genesis of many tumour types. Science 1994; 264:436-40.
27. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-6.
28. Stone S, Dayananth P, Jiang P, Weaver-Feldhaus JM, Tavtigian SV, Cannon-Albright L, et al. Genomic structure, expression and mutational analysis of the p15 (MTS2) gene. Oncogene 1995;11:987-91.
29. INKHI/ MTS2 in human leukemias and lymphomas. Cancer Res 1995;55:1436-40.
30. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, et al. Complex structure and regulation of the p16 (MTS1) locus. Cancer Res 1995;55:2988-94.
31. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Dracopoli NC. Germline p16 mutations in familial melanoma. Nat Genet 1994;8:15-21.
32. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) mactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56:3630-3.
33. INKHI. Caacer Res 1996;56:722-7.